Once versus divided daily dosing with delayed-release mesalazine: a study of tissue drug concentrations and standard pharmacokinetic parameters
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2036.2001.00891.x/fullpdf
Reference31 articles.
1. Sulphasalazine and salicylazosulphadimidine in ulcerative colitis;Baron;Lancet,1962
2. Controlled trial of sulphasalazine in the treatment of ulcerative colitis;Dick;Gut,1964
3. Controlled trial of sulphasalazine in maintenance therapy for ulcerative colitis;Misiewicz;Lancet,1965
4. A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine (salazopyrin);Dissanayake;Gut,1973
5. Sulfasalazine intolerance: a retrospective survey of the reasons for discontinuing treatment with sulphasalazine in patients with chronic inflammatory bowel disease;Nielson;Scand J Gastroenterol,1982
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Common Mistakes in Managing Patients with Inflammatory Bowel Disease;Journal of Clinical Medicine;2024-08-14
2. Further Validation of the Crohn’s and Ulcerative Colitis Questionnaire-32 (CUCQ-32) to Measure the Quality of Life in Patients Treated with Biologics Therapy;Clinics and Practice;2022-06-10
3. Similar pharmacokinetics of three dosing regimens comprising two oral delayed‐release mesalamine formulations in healthy adult volunteers: Randomised, open‐label, parallel‐group study;British Journal of Clinical Pharmacology;2020-08-10
4. Modern use of 5-aminosalicylic acid compounds for ulcerative colitis;Expert Opinion on Biological Therapy;2019-09-18
5. Does the 5-Aminosalicylate Concentration Correlate with the Efficacy of Oral 5-Aminosalicylate and Predict Response in Patients with Inflammatory Bowel Disease? A Systematic Review;Digestion;2019-04-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3